Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romidepsin in HIV-Infected Adults With Suppressed Viremia
NCT01933594Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- May 2014
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of romidepsin in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Started May 2014; status: completed.
02
Drugs
romidepsin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01933594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01933594.